Alecensa 150 mg hard capsules
NL77596.042.21
Approved small_molecule active
Quick answer
Alecensa 150 mg hard capsules for ALK positive non-small cell lung cancer is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- ALK positive non-small cell lung cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active